GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:
Meda (STO:MEDAA) has agreed to acquire three well-established Nordic OTC drugs from McNeil AB/Cilag GmbH International, members of the Johnson & Johnson Consumer Companies. Treo is the main drug. Annual sales for all three products total approximately 210 MSEK.
Meda (STO:MEDAA) has agreed to acquire three well-established Nordic OTC drugs from McNeil AB/Cilag GmbH International, members of the Johnson & Johnson Consumer Companies. Treo is the main drug. Annual sales for all three products total approximately 210 MSEK.
